Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03686150 · ClinicalTrials.gov registry record · NA
Vitamin D Oral Replacement in Asthma
A NA study of Asthma and Vitamin D Deficiency, sponsored by IDeA States Pediatric Clinical Trials Network.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 15
- Study locations
NCT03686150: Completed NA study of Asthma and Vitamin D Deficiency, sponsored by IDeA States Pediatric Clinical Trials Network.
NCT03686150 is a NA study of Asthma and Vitamin D Deficiency that has completed, run by IDeA States Pediatric Clinical Trials Network. The registered enrollment target is 112 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower). The trial reports 15 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03686150, a NA study of Asthma and Vitamin D Deficiency, has completed, sponsored by IDeA States Pediatric Clinical Trials Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 15
- Study locations
Study Summary
The overall objective of the study is to determine the pharmacokinetics of Vitamin D supplementation in children who have asthma and are overweight or obese.
Primary Outcome
Determine the best vitamin D supplementation level based on PK analysis of participants enrolled in Part 1. The PK of 25(OH)D after vitamin D supplementation in children will be characterized using a 2-compartment population PK model (popPK) with linear absorption and elimination kinetics.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Vitamin D3 oral regimen
Study Locations (15)
Arkansas
- Arkansas Children's Hospital - Little Rock
Delaware
- Nemours/Alfred I duPont Hospital for Children - Wilmington
Hawaii
- Kapiolani Medical Center for Women and Children - Honolulu
Kentucky
- University of Louisville - Louisville
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Mississippi
- University of Mississippi Medical Center - Jackson
Missouri
- Children's Mercy Hospital - Kansas City
Montana
- Community Medical Center - Missoula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2019-01-30 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
What the finished NCT03686150 record still lists
NCT03686150 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D3 oral regimen is the first listed.
NCT03686150 lists 15 locations in 15 states (Arkansas, Delaware, Hawaii).
Frequently Asked Questions
What is clinical trial NCT03686150 about?
NCT03686150 is a clinical study titled "Vitamin D Oral Replacement in Asthma". The overall objective of the study is to determine the pharmacokinetics of Vitamin D supplementation in children who have asthma and are overweight or obese.
What is the current status of trial NCT03686150?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2019-01-30. Estimated completion is 2021-09-30.
What conditions does trial NCT03686150 study?
This clinical trial studies the following conditions: Asthma, Vitamin D Deficiency, Pediatric Obesity.
What interventions are being tested in trial NCT03686150?
The interventions under investigation include: Vitamin D3 oral regimen (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03686150?
This trial is sponsored by IDeA States Pediatric Clinical Trials Network, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03686150 being conducted?
This trial has 15 study locations across Arkansas, Delaware, Hawaii, Kentucky, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03686150's enrollment target sits among peer trials
112 207th of 374 higher than 167 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI